,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,410,1,5,,11113412,33032,Inconclusive,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
1,411,2,1,,11113412,33032,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
2,445,3,1,,11113412,33032,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
3,447,1,1,,11113412,33032,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
4,448,1,2,,11113412,33032,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
5,450,1,2,,11113412,33032,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
6,451,1,2,,11113412,33032,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
7,526,1,1,,11113412,33032,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
8,530,1,1,,11113412,33032,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
9,584,1,3,,11113412,33032,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
10,585,1,4,,11113412,33032,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
11,595,1,3,,11113412,33032,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
12,596,1,2,,11113412,33032,Inconclusive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
13,597,1,3,,11113412,33032,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
14,603,1,2,,11113412,33032,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
15,605,1,2,,11113412,33032,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
16,607,1,3,,11113412,33032,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
17,662,1,1,,11113412,33032,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
18,875,1,2,,11113412,33032,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
19,880,2,1,,11113412,33032,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
20,880,2,1,,11113412,33032,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
21,880,2,1,,26751652,33032,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
22,880,2,1,,26751652,33032,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
23,881,2,2,,11113412,33032,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
24,883,1,3,,11113412,33032,Inactive,13699818.0,1559.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
25,884,1,2,,11113412,33032,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
26,885,1,2,,11113412,33032,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
27,886,1,2,,11113412,33032,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
28,886,1,2,,11113412,33032,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
29,887,1,2,,11113412,33032,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
30,889,1,3,,11113412,33032,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
31,891,1,2,,11113412,33032,Inactive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
32,892,1,2,,11113412,33032,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
33,893,1,2,,11113412,33032,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
34,893,1,2,,11113412,33032,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
35,894,2,1,,11113412,33032,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
36,899,1,2,,11113412,33032,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
37,900,1,3,,11113412,33032,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
38,901,1,2,,11113412,33032,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
39,902,1,2,,11113412,33032,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
40,912,1,2,,11113412,33032,Inconclusive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
41,923,1,2,,11113412,33032,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
42,924,1,2,,11113412,33032,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
43,926,1,2,,11113412,33032,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
44,938,1,2,,11113412,33032,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
45,995,1,2,,11113412,33032,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
46,1030,2,1,,11113412,33032,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
47,1030,2,1,,26751652,33032,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
48,1189,1,5,,48413815,33032,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
49,1194,1,3,,48413815,33032,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
50,1195,1,2,,48416058,33032,Active,,,,,DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database,Other,,
51,1199,1,3,,48413815,33032,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
52,1379,1,2,,11113412,33032,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
53,1452,1,1,,11113412,33032,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
54,1454,1,1,,11113412,33032,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
55,1457,1,1,,11113412,33032,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
56,1457,1,1,,26751652,33032,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
57,1458,1,1,,26751652,33032,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
58,1460,1,3,,11113412,33032,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
59,1460,1,3,,26751652,33032,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
60,1463,1,1,,11113412,33032,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
61,1463,1,1,,26751652,33032,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
62,1467,1,3,,11113412,33032,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
63,1468,1,1,,11113412,33032,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
64,1468,1,1,,26751652,33032,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
65,1469,1,1,,11113412,33032,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
66,1469,1,1,,26751652,33032,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
67,1471,2,1,,11113412,33032,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
68,1471,2,1,,26751652,33032,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
69,1476,2,1,,11113412,33032,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
70,1477,1,1,,11113412,33032,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
71,1477,1,1,,26751652,33032,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
72,1478,2,1,,11113412,33032,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
73,1479,1,2,,11113412,33032,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
74,1479,1,2,,26751652,33032,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
75,1490,2,1,,11113412,33032,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
76,1490,2,1,,26751652,33032,Active,10954339.0,,50.1187,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
77,1519,1,3,,11113412,33032,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
78,1766,1,1,,11113412,33032,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
79,1766,1,1,,11113412,33032,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
80,1768,1,1,,11113412,33032,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
81,1768,1,1,,11113412,33032,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
82,1811,3,2,,46391925,33032,Active,11514178.0,,,,Experimentally measured binding affinity data derived from PDB,Other,11086992.0,
83,1811,3,2,,46392220,33032,Active,15988294.0,,,,Experimentally measured binding affinity data derived from PDB,Other,11518533.0,
84,1811,3,2,,46393547,33032,Active,55670838.0,,,,Experimentally measured binding affinity data derived from PDB,Other,8805567.0,
85,1851,1,2,,11113412,33032,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
86,1851,1,2,1.0,11113412,33032,Inactive,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
87,1851,1,2,2.0,11113412,33032,Inactive,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
88,1851,1,2,3.0,11113412,33032,Inactive,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
89,1851,1,2,4.0,11113412,33032,Inconclusive,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
90,1851,1,2,5.0,11113412,33032,Inactive,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
91,1865,1,1,,11113412,33032,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
92,1865,1,1,,26751652,33032,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
93,1948,1,1,,11113412,33032,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
94,2101,1,1,,11113412,33032,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
95,2101,1,1,,26751652,33032,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
96,2107,1,1,,11113412,33032,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
97,2107,1,1,,26751652,33032,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
98,2112,1,1,,11113412,33032,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
99,2112,1,1,,26751652,33032,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
100,2147,1,1,,11113412,33032,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
101,2451,1,2,,11113412,33032,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
102,2472,1,2,,11113412,33032,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
103,2517,2,1,,11113412,33032,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
104,2517,2,1,,144206604,33032,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
105,2528,1,2,,11113412,33032,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
106,2546,1,1,,11113412,33032,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
107,2549,1,1,,11113412,33032,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
108,2549,1,1,,26751652,33032,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
109,2551,1,1,,11113412,33032,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
110,2660,1,1,,90340902,33032,Inactive,4826730.0,2475.0,,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
111,2666,1,1,,90340902,33032,Inactive,4826730.0,2475.0,,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
112,2667,1,1,,90340902,33032,Inactive,4826730.0,2475.0,,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
113,2668,1,1,,90340902,33032,Inactive,4826730.0,2475.0,,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
114,18077,6,2,,103699331,33032,Active,,,1.65,Km,Compound was evaluated for the kinetic parameter (Km),Confirmatory,10498218.0,
115,22598,7,1,,103699331,33032,Unspecified,,,,,Compound was evaluated for the kinetic parameter Vmax (maximum velocity),Other,10498218.0,
116,22733,5,2,,103699331,33032,Unspecified,,,,,Ischemic myocardial half-life measured after intracoronary injection of [13N]-labeled amino acid in dogs (control - 114.1+/-26.5),Other,7252987.0,
117,25112,3,3,,103699331,33032,Unspecified,,,,,Acid dissociation constant was calculated (3 determinations),Other,9046343.0,
118,26351,4,4,,103699331,33032,Unspecified,,,,,pKa value was determined,Other,6818345.0,
119,26365,4,3,,103699331,33032,Unspecified,,,,,pKa value by 1H NMR titration experiments; pK1,Other,8558509.0,
120,26366,4,3,,103699331,33032,Unspecified,,,,,pKa value by 1H NMR titration experiments; pK2,Other,8558509.0,
121,26367,4,3,,103699331,33032,Unspecified,,,,,pKa value by 1H NMR titration experiments; pK3,Other,8558509.0,
122,26636,3,3,,103699331,33032,Unspecified,,,,,"The dissociation constant at alpha-carboxyl group in water at 20 degree Centigrade. (evaluated by Uyeno., Y et. al.)",Other,10514280.0,
123,26797,4,1,,103699331,33032,Unspecified,,,,,Partition coefficient (logP),Other,3656360.0,
124,26845,3,3,,103699331,33032,Unspecified,,,,,"The dissociation constant at omega-carboxyl or hydroxyl group iin water at 20 degree Centigrade. (evaluated by Uyeno., Y et. al.)",Other,10514280.0,
125,26874,3,3,,103699331,33032,Unspecified,,,,,"The dissociation constant at ammonium group in water at 20 degree Centigrade. (evaluated by Uyeno., Y et. al.)",Other,10514280.0,
126,30257,4,7,,103699331,33032,Unspecified,,,,,Effect of pretreatment on the Acetylcholinesterase (AChE) activity when exposed to glutamate,Other,11078202.0,
127,39376,6,2,,103699331,33032,Active,,,7.5,IC50,In vitro binding affinity against synaptic membrane from rat brain using [3H](R)-Asp as the radioligand,Confirmatory,2552114.0,
128,57548,6,3,,103699331,33032,Active,,,35.2,EC50,Compound was tested for agonistic activity on rat dorsal root ganglion neurons (thought to express GluR5 receptors),Confirmatory,10969973.0,
129,57550,3,7,,103699331,33032,Unspecified,,,,,Agonistic activity of compound on rat dorsal root ganglion cells was expressed as percentage Rmax,Other,10969973.0,
130,58931,3,3,,103699331,33032,Unspecified,,,,,Ischemic myocardial residue fraction of [13N]-labeled amino acid was observed with a single pass uptake technique in open-chest instrumented dogs (control - 8.1+/-3.1),Other,7252987.0,
131,66956,7,1,,103699331,33032,Active,,,,,Steady state transport rate by EAAC1 (EAAT3) in mammalian cells,Other,11472204.0,
132,74669,9,5,,103699331,33032,Active,417584.0,,28.0,Ki,Inhibition towards glutamate racemase from Lactobacillus fermenti was determined and expressed as KI,Confirmatory,,
133,74816,6,3,,103699331,33032,Unspecified,,,75.0,EC50,Compound was tested for agonistic activity at Glutamate receptor 5 using HEK293 cells,Confirmatory,10969973.0,
134,74817,3,7,,103699331,33032,Unspecified,,,,,Agonistic activity of compound on Glutamate receptor 5 using cell membranes prepared from HEK293 cells was expressed as percentage Rmax,Other,10969973.0,
135,74818,6,3,,103699331,33032,Active,,,25.0,EC50,Compound was tested for agonistic activity at Glutamate receptor 6 using HEK293 cells,Confirmatory,10969973.0,
136,74820,5,3,,103699331,33032,Inconclusive,,,,,Agonistic activity of compound on Glutamate receptor 6 using cell membranes prepared from HEK293 cells was expressed as percentage Rmax; ND means Not determined,Other,10969973.0,
137,74822,9,1,,103699331,33032,Active,,,0.75,Ki,Binding affinity of compound was determined against Glutamate receptor (KA2) using cell membranes prepared from HEK293 cells,Confirmatory,10969973.0,
138,74830,4,9,,103699331,33032,Unspecified,,,,,Tested for the ability to attenuate the sodium-dependent uptake of [3H]D-aspartate (5 uM) into synaptosomes prepared from rat forebrain at 25 uM,Other,,
139,74833,5,6,,103699331,33032,Inconclusive,,,,,Tested for the ability to attenuate the sodium-dependent uptake of [3H]D-aspartate (5 uM) into synaptosomes prepared from rat forebrain at 250 uM; ND means no data,Other,,
140,74835,3,6,,103699331,33032,Unspecified,,,,,Inhibitory activity against vesicular glutamate transport (GVT) in synaptic vesicles isolated from rat forebrain,Other,10498218.0,
141,75015,6,2,,103699331,33032,Active,,,4.9,EC50,The effective concentration for 50% glutamate response was measured on Group I Metabotropic glutamate receptor,Confirmatory,10425091.0,
142,75021,6,2,,103699331,33032,Active,,,0.29,EC50,The effective concentration for 50% glutamate response was measured on Group II Metabotropic glutamate receptor,Confirmatory,10425091.0,
143,75159,8,2,,103699331,33032,Active,,,1.9,EC50,Compound was tested for the inhibition of Group II Metabotropic glutamate receptor (mGluR3/1a).,Confirmatory,9572889.0,
144,82377,6,2,,103699331,33032,Active,,,35.2,EC50,Effective concentration against Dorsal root ganglia (DRG) neurones,Confirmatory,10821708.0,
145,82378,3,4,,103699331,33032,Unspecified,,,,,Whole-cell voltage clamp recordings made from acutely isolated dorsal root ganglion neurons and Rmax value is reported.,Other,10821708.0,
146,91444,3,7,,103699331,33032,Unspecified,,,,,Depolarizing potency in Ionotropic glutamate receptor kainate sensitive neurons in the immature rat dorsal roots,Other,8558509.0,
147,92041,3,7,,103699331,33032,Unspecified,,,,,Percent control measured by evaluating the inhibition of 3 nM [125I]PhTX-343-lysine binding to glutamate receptors in rat cortical membranes,Other,1652018.0,
148,92350,9,2,,103699331,33032,Active,,,0.5,IC50,Binding affinity was measured by [3H]- Ionotropic glutamate receptor AMPA binding assay.,Confirmatory,1370693.0,
149,92356,9,2,,103699331,33032,Active,,,0.15,IC50,Compound was evaluated for the inhibition of [3H]AMPA binding to Ionotropic glutamate receptor AMPA from rat brain synaptic membrane.,Confirmatory,,
150,92497,9,2,,103699331,33032,Active,,,1.2,IC50,Inhibition of specific binding of [3H]AMPA to Ionotropic glutamate receptor AMPA in rat brain membranes,Confirmatory,9379437.0,
151,92501,9,2,,103699331,33032,Active,,,1.3,IC50,Tested for inhibition of Specific DL-[H]Ionotropic glutamate receptor AMPA binding to rat brain membranes,Confirmatory,6133955.0,
152,92646,9,2,,103699331,33032,Active,,,1.1,Ki,Binding affinity towards AMPA receptor by displacement of [3H]AMPA radioligand.,Confirmatory,11472204.0,
153,92951,9,5,,103699331,33032,Active,116242505.0,2890.0,1.36,Ki,Displacement of [3H]AMPA from human Ionotropic glutamate receptor AMPA 1 expressed in HEK293 cells,Confirmatory,9357531.0,
154,92952,9,1,,103699331,33032,Active,,,1.36,Ki,Binding affinity of compound was determined against Ionotropic glutamate receptor AMPA 1 using cell membranes prepared from HEK293 cells,Confirmatory,10969973.0,
155,92953,7,1,,103699331,33032,Active,,,1.3619999999999999,Ki,Compound was tested for binding affinity against human Ionotropic glutamate receptor AMPA 1 in HEK293 cells using [3H]-AMPA as radioligand,Confirmatory,10821708.0,
156,92962,8,5,,103699331,33032,Active,23831146.0,2891.0,0.94,Ki,Displacement of [3H]AMPA from human Ionotropic glutamate receptor AMPA 2 expressed in HEK293 cells,Confirmatory,9357531.0,
157,92963,9,1,,103699331,33032,Active,,,0.94,Ki,Binding affinity of compound was determined against Ionotropic glutamate receptor AMPA 2 using cell membranes prepared from HEK293 cells,Confirmatory,10969973.0,
158,92964,7,1,,103699331,33032,Active,,,0.94,Ki,Compound was tested for binding affinity against human Ionotropic glutamate receptor AMPA 2 in HK293 cells using [3H]AMPA as radioligand,Confirmatory,10821708.0,
159,93111,9,5,,103699331,33032,Active,218512059.0,2893.0,0.868,Ki,Displacement of [3H]AMPA from human Ionotropic glutamate receptor AMPA 4 expressed in HEK293 cells,Confirmatory,9357531.0,
160,93112,9,1,,103699331,33032,Active,,,0.868,Ki,Binding affinity of compound was determined against Ionotropic glutamate receptor AMPA 4 using cell membranes prepared from HEK293 cells,Confirmatory,10969973.0,
161,93113,7,1,,103699331,33032,Active,,,0.868,Ki,Compound was tested for binding affinity against human Ionotropic glutamate receptor AMPA 4 in HEK293 cells using [3H]AMPA as radioligand,Confirmatory,10821708.0,
162,93243,7,6,,103699331,33032,Unspecified,729597.0,2897.0,75.0,EC50,Effective concentration against GluR5 expressed in HEK293 cells,Confirmatory,10821708.0,
163,93247,9,1,,103699331,33032,Active,,,0.701,Ki,Binding affinity of compound was determined against Ionotropic glutamate receptor ionotropic kainate 1 using cell membranes prepared from HEK293 cells,Confirmatory,10969973.0,
164,93250,7,1,,103699331,33032,Active,,,0.701,Ki,Binding affinity against human ionotropic glutamate receptor kainate 1 in HK293 cells using [3H]kainate as radioligand,Confirmatory,10821708.0,
165,93251,3,6,,103699331,33032,Unspecified,,,,,Whole-cell voltage clamp recordings made from HEK293 cells stably transfected with Ionotropic glutamate receptor ionotropic kainate 1.Results are expressed as % of maximum inward current evoked,Other,10821708.0,
166,93254,8,5,,103699331,33032,Active,209572626.0,2901.0,0.701,Ki,Displacement of [3H]kainate from human Ionotropic glutamate receptor ionotropic kainate 1 expressed in HEK293 cells,Confirmatory,9357531.0,
167,93262,6,7,,103699331,33032,Active,2492627.0,2898.0,25.0,EC50,Effective concentration against human GluR6 expressed in HEK293 cells,Confirmatory,10821708.0,
168,93265,9,1,,103699331,33032,Active,,,1.1059999999999999,Ki,Binding affinity of compound was determined against Ionotropic glutamate receptor ionotropic kainate 2 using cell membranes prepared from HEK293 cells,Confirmatory,10969973.0,
169,93395,8,5,,103699331,33032,Active,2492627.0,2898.0,1.1059999999999999,Ki,Binding affinity against human GluR6,Confirmatory,10821708.0,
170,93397,3,10,,103699331,33032,Unspecified,2492627.0,2898.0,,,Whole-cell voltage clamp recordings made from HEK293 cells stably transfected with human Ionotropic glutamate receptor ionotropic GluR6.Results are expressed as % of maximum inward current evoked,Other,10821708.0,
171,93407,7,2,,103699331,33032,Active,,,0.789,Ki,Ability to bind to Ionotropic glutamate receptor ionotropic kainate 3 was evaluated,Confirmatory,10821708.0,
172,93408,9,1,,103699331,33032,Active,,,0.789,Ki,Binding affinity of compound was determined against Ionotropic glutamate receptor ionotropic kainate 3 using cell membranes prepared from HEK293 cells,Confirmatory,10969973.0,
173,93411,7,2,,103699331,33032,Active,,,0.75,Ki,Ability to bind to Ionotropic glutamate receptor kainate (kainate 2) was evaluated.,Confirmatory,10821708.0,
174,93557,9,1,,103699331,33032,Active,,,0.35,IC50,Binding affinity against Ionotropic glutamate receptor kainate by displacing [3H]KA from purified rat synaptic membranes,Confirmatory,2985786.0,
175,93565,9,2,,103699331,33032,Active,,,0.4,IC50,Binding affinity was measured by [3H]- KAIN receptor binding assay.,Confirmatory,1370693.0,
176,93569,9,2,,103699331,33032,Active,,,0.4,IC50,Compound tested for binding affinity towards Ionotropic glutamate receptor kainate,Confirmatory,6325690.0,
177,93572,9,2,,103699331,33032,Active,,,0.12,IC50,Compound was evaluated for the inhibition of [3H]-KA binding to Ionotropic glutamate receptor kainate from rat brain synaptic membrane.,Confirmatory,,
178,93719,9,2,,103699331,33032,Active,,,0.7,IC50,Inhibition of specific binding of [3H]kainate to Ionotropic glutamate receptor kainate in rat brain membranes,Confirmatory,9379437.0,
179,93739,9,2,,103699331,33032,Active,,,0.063,Ki,Binding affinity towards Ionotropic glutamate receptor kainate by displacement of [3H]-kainic acid radioligand,Confirmatory,11472204.0,
180,107059,6,3,,103699331,33032,Active,,,11.4,Ki,Agonist potency against cloned metabotropic glutamate receptor 5,Confirmatory,10893301.0,
181,107062,9,2,,103699331,33032,Active,,,4.4,EC50,Compound was evaluated for the inhibitory activity against cloned Metabotropic glutamate receptor 5,Confirmatory,12213064.0,
182,107063,9,1,,103699331,33032,Active,,,10.0,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR5a in rat,Confirmatory,7738999.0,
183,107064,9,1,,103699331,33032,Active,,,8.0,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR5b in rat,Confirmatory,7738999.0,
184,107083,9,2,,103699331,33032,Active,,,3.1,EC50,Compound was tested for the inhibition of Metabotropic glutamate receptor 5,Confirmatory,9572889.0,
185,107091,3,10,,103699331,33032,Active,239938639.0,2916.0,,,Inhibition of c-AMP by human Metabotropic glutamate receptor 6 (mGluR6) expressed in non-neuronal cells,Other,12166935.0,
186,107093,6,3,,103699331,33032,Active,,,38.0,Ki,Agonist potency against cloned Metabotropic glutamate receptor 6 (mGluR-6).,Confirmatory,10893301.0,
187,107240,9,1,,103699331,33032,Active,,,16.0,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR6 in rat,Confirmatory,7738999.0,
188,107251,6,3,,103699331,33032,Active,,,20.0,EC50,Agonistic activity at mGlu6 receptor expressed in CHO cells,Confirmatory,8759641.0,
189,107253,9,2,,103699331,33032,Active,,,4.9,EC50,Compound was tested for the inhibition of Metabotropic glutamate receptor 6,Confirmatory,9572889.0,
190,107256,3,10,,103699331,33032,Unspecified,2495078.0,2917.0,,,Inhibition of c-AMP by human Metabotropic glutamate receptor 7 (mGluR7) expressed in non-neuronal cells,Other,12166935.0,
191,107260,6,5,,103699331,33032,Unspecified,,,500.0,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR7 in human,Confirmatory,7738999.0,
192,107261,6,4,,103699331,33032,Unspecified,,,5400.0,Ki,Agonist potency against cloned Metabotropic glutamate receptor 7 (mGluR-7).,Confirmatory,10893301.0,
193,107263,6,3,,103699331,33032,Unspecified,,,1000.0,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR7 in rat,Confirmatory,7738999.0,
194,107274,6,3,,103699331,33032,Active,,,9.5,Ki,Agonist potency against cloned Metabotropic glutamate receptor 8 (mGluR-8).,Confirmatory,10893301.0,
195,107403,9,2,,103699331,33032,Active,,,0.022000000000000002,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR8 in mouse,Confirmatory,7738999.0,
196,107404,6,3,,103699331,33032,Active,,,8.0,EC50,Agonist activity in rat at Metabotropic glutamate receptor 8 expressed in HEK293 cells,Confirmatory,11412983.0,
197,108354,3,10,,103699331,33032,Active,311033443.0,2911.0,,,Phosphoinositide hydrolysis by human Metabotropic glutamate receptor 1 (mGluR1) expressed in non-neuronal cells,Other,12166935.0,
198,108357,6,4,,103699331,33032,Unspecified,,,156.0,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR1b in human,Confirmatory,7738999.0,
199,108489,6,3,,103699331,33032,Active,,,10.0,Ki,Agonist potency against cloned human metabotropic glutamate receptor 1,Confirmatory,10893301.0,
200,108493,9,5,,103699331,33032,Active,121300.0,24414.0,0.34,Ki,Inhibition of binding to rat mGluR1a (metabotropic glutamate receptor) expressed in HEK-293 cells,Confirmatory,12109902.0,
201,108495,6,3,,103699331,33032,Active,,,3.0,EC50,Agonist activity in rat at Metabotropic glutamate receptor 1 expressed in HEK293 cells,Confirmatory,11412983.0,
202,108497,9,2,,103699331,33032,Active,,,10.0,EC50,Compound was evaluated for the inhibitory activity against cloned Metabotropic glutamate receptor 1,Confirmatory,12213064.0,
203,108498,9,1,,103699331,33032,Active,,,9.0,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR1a in rat,Confirmatory,7738999.0,
204,108499,9,1,,103699331,33032,Unspecified,,,56.0,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR1b in rat,Confirmatory,7738999.0,
205,108500,9,1,,103699331,33032,Active,,,13.0,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR1c in rat,Confirmatory,7738999.0,
206,108506,4,6,,103699331,33032,Unspecified,,,,,Ratio between EC50 of compound and glutamate measured against metabotropic glutamate receptor 1,Other,10229625.0,
207,108645,6,4,,103699331,33032,Active,,,19.0,EC50,Agonistic activity at mGlu1-alpha receptor expressed in CHO cells,Confirmatory,8759641.0,
208,108647,9,2,,103699331,33032,Active,,,4.9,EC50,Compound was tested for the inhibition of Metabotropic glutamate receptor 1,Confirmatory,9572889.0,
209,108660,6,3,,103699331,33032,Active,,,1.05,EC50,Effect of compound on Metabotropic glutamate receptor 1 expressed in HEK 293 cells was determined by measuring IP production relative to glutamate,Confirmatory,10673095.0,
210,108669,3,10,,103699331,33032,Active,76803802.0,2912.0,,,Inhibition of c-AMP by human Metabotropic glutamate receptor 2 (mGluR2) expressed in non-neuronal cells,Other,12166935.0,
211,108677,9,2,,103699331,33032,Active,,,4.7,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR2 in human,Confirmatory,7738999.0,
212,108836,6,3,,103699331,33032,Active,,,12.0,Ki,Potency against cloned Metabotropic glutamate receptor 2 agonist,Confirmatory,10893301.0,
213,108837,9,2,,103699331,33032,Active,,,1.2,Ki,Binding affinity at Metabotropic glutamate receptor 2,Confirmatory,12109902.0,
214,108839,6,3,,103699331,33032,Active,,,16.0,EC50,Agonist activity in rat at Metabotropic glutamate receptor 2 expressed in HEK293 cells,Confirmatory,11412983.0,
215,108844,9,2,,103699331,33032,Active,,,4.0,EC50,Compound was evaluated for the inhibitory activity against cloned Metabotropic glutamate receptor 2,Confirmatory,12213064.0,
216,108845,9,5,,103699331,33032,Active,400253.0,24415.0,4.0,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR2 in rat,Confirmatory,7738999.0,
217,108985,4,6,,103699331,33032,Unspecified,,,,,Ratio between EC50 of compound and glutamate measured against Metabotropic glutamate receptor 2,Other,10229625.0,
218,109003,6,4,,103699331,33032,Active,,,8.5,EC50,Agonistic activity at mGlu2 receptor expressed in CHO cells,Confirmatory,8759641.0,
219,109004,9,2,,103699331,33032,Active,,,0.29,EC50,Compound was tested for the inhibition of metabotropic glutamate receptor 2 (mGluR2).,Confirmatory,9572889.0,
220,109149,3,10,,103699331,33032,Active,76803803.0,2913.0,,,Inhibition of c-AMP by human Metabotropic glutamate receptor 3 (mGluR3) expressed in non-neuronal cells,Other,12166935.0,
221,109164,6,3,,103699331,33032,Active,,,9.0,Ki,Agonist potency against cloned Metabotropic glutamate receptor 3 (mGluR-3).,Confirmatory,10893301.0,
222,109170,9,1,,103699331,33032,Active,,,3.0,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR3 in rat,Confirmatory,7738999.0,
223,109323,3,10,,103699331,33032,Active,2495077.0,2914.0,,,Inhibition of c-AMP by human Metabotropic glutamate receptor 4 (mGluR4) expressed in non-neuronal cells,Other,12166935.0,
224,109333,9,2,,103699331,33032,Active,,,20.0,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR4a in human,Confirmatory,7738999.0,
225,109341,6,3,,103699331,33032,Active,,,17.0,Ki,Agonist potency against cloned human Metabotropic glutamate receptor 4 (mGluR-4),Confirmatory,10893301.0,
226,109463,9,2,,103699331,33032,Active,,,1.6,Ki,Binding affinity at Metabotropic glutamate receptor 4,Confirmatory,12109902.0,
227,109465,9,2,,103699331,33032,Active,,,12.0,EC50,Compound was evaluated for the inhibitory activity against cloned Metabotropic glutamate receptor 4,Confirmatory,12213064.0,
228,109466,9,5,,103699331,33032,Active,400255.0,24417.0,5.0,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR4a in rat,Confirmatory,7738999.0,
229,109477,9,2,,103699331,33032,Active,,,9.8,EC50,Compound was tested for the inhibition of Metabotropic glutamate receptor 4,Confirmatory,9572889.0,
230,109484,6,3,,103699331,33032,Active,,,15.0,EC50,Agonistic activity at mGlu4a receptor expressed in CHO cells,Confirmatory,8759641.0,
231,109491,3,10,,103699331,33032,Active,1709020.0,2915.0,,,Phosphoinositide hydrolysis by human Metabotropic glutamate receptor 5 (mGluR5) expressed in non neuronal cells,Other,12166935.0,
232,109493,9,2,,103699331,33032,Active,,,4.1,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR5a in human,Confirmatory,7738999.0,
233,143783,8,2,,103699331,33032,Active,,,0.2,IC50,Binding affinity was measured by NMDA sensitive [3H]- glutamic acid receptor binding assay.,Confirmatory,1370693.0,
234,143921,3,11,,103699331,33032,Unspecified,121434.0,29628.0,,,"Depolarizing activity relative to that of L-Glutamate (L-Glu=1) tested against mixed type (N-methyl-D-aspartate glutamate receptor, Ionotropic glutamate receptor AMPA) receptor in the newborn rat spinal motoneurone",Other,,
235,143921,3,11,,103699331,33032,Unspecified,121435.0,29629.0,,,"Depolarizing activity relative to that of L-Glutamate (L-Glu=1) tested against mixed type (N-methyl-D-aspartate glutamate receptor, Ionotropic glutamate receptor AMPA) receptor in the newborn rat spinal motoneurone",Other,,
236,143921,3,11,,103699331,33032,Unspecified,548372.0,24410.0,,,"Depolarizing activity relative to that of L-Glutamate (L-Glu=1) tested against mixed type (N-methyl-D-aspartate glutamate receptor, Ionotropic glutamate receptor AMPA) receptor in the newborn rat spinal motoneurone",Other,,
237,143921,3,11,,103699331,33032,Unspecified,548374.0,24411.0,,,"Depolarizing activity relative to that of L-Glutamate (L-Glu=1) tested against mixed type (N-methyl-D-aspartate glutamate receptor, Ionotropic glutamate receptor AMPA) receptor in the newborn rat spinal motoneurone",Other,,
238,143921,3,11,,103699331,33032,Unspecified,548379.0,24408.0,,,"Depolarizing activity relative to that of L-Glutamate (L-Glu=1) tested against mixed type (N-methyl-D-aspartate glutamate receptor, Ionotropic glutamate receptor AMPA) receptor in the newborn rat spinal motoneurone",Other,,
239,143921,3,11,,103699331,33032,Unspecified,3287964.0,29627.0,,,"Depolarizing activity relative to that of L-Glutamate (L-Glu=1) tested against mixed type (N-methyl-D-aspartate glutamate receptor, Ionotropic glutamate receptor AMPA) receptor in the newborn rat spinal motoneurone",Other,,
240,143921,3,11,,103699331,33032,Unspecified,3915771.0,24409.0,,,"Depolarizing activity relative to that of L-Glutamate (L-Glu=1) tested against mixed type (N-methyl-D-aspartate glutamate receptor, Ionotropic glutamate receptor AMPA) receptor in the newborn rat spinal motoneurone",Other,,
241,143921,3,11,,103699331,33032,Unspecified,18202594.0,24412.0,,,"Depolarizing activity relative to that of L-Glutamate (L-Glu=1) tested against mixed type (N-methyl-D-aspartate glutamate receptor, Ionotropic glutamate receptor AMPA) receptor in the newborn rat spinal motoneurone",Other,,
242,143921,3,11,,103699331,33032,Unspecified,51701630.0,170796.0,,,"Depolarizing activity relative to that of L-Glutamate (L-Glu=1) tested against mixed type (N-methyl-D-aspartate glutamate receptor, Ionotropic glutamate receptor AMPA) receptor in the newborn rat spinal motoneurone",Other,,
243,143921,3,11,,103699331,33032,Unspecified,51701631.0,191573.0,,,"Depolarizing activity relative to that of L-Glutamate (L-Glu=1) tested against mixed type (N-methyl-D-aspartate glutamate receptor, Ionotropic glutamate receptor AMPA) receptor in the newborn rat spinal motoneurone",Other,,
244,143921,3,11,,103699331,33032,Unspecified,97536283.0,50592.0,,,"Depolarizing activity relative to that of L-Glutamate (L-Glu=1) tested against mixed type (N-methyl-D-aspartate glutamate receptor, Ionotropic glutamate receptor AMPA) receptor in the newborn rat spinal motoneurone",Other,,
245,144321,9,2,,103699331,33032,Active,,,0.12,EC50,Compound was evaluated for the inhibition of [3H]MK-801 binding at N-methyl-D-aspartate glutamate receptor,Confirmatory,1361579.0,
246,144333,3,6,,103699331,33032,Active,,,,,Binding affinity for glutamate-stimulated TCP binding site of N-methyl-D-aspartate glutamate receptor from rat brain by using [3H]-TCP as radioligand; ag = agonist,Other,2145436.0,
247,144456,9,2,,103699331,33032,Active,,,1.0,IC50,Displacement of [3H]CPP from N-methyl-D-aspartate glutamate receptor in rat brain membrane,Confirmatory,1533422.0,
248,144612,9,2,,103699331,33032,Active,,,0.172,IC50,"Compound was evaluated for the inhibition of [3H]-CGS-19,755 binding at N-methyl-D-aspartate glutamate receptor",Confirmatory,1361579.0,
249,144621,9,2,,103699331,33032,Active,,,0.171,IC50,Inhibition of N-methyl-D-aspartate glutamate receptor by using [3H]CPP as a radioligand from the rat cortical membranes.,Confirmatory,2145436.0,
250,144837,9,2,,103699331,33032,Active,,,0.08,IC50,"Compound was evaluated for the inhibition of [3H]CGS-19,755 binding to NMDA receptor from rat brain synaptic membrane.",Confirmatory,,
251,145038,9,5,,103699331,33032,Active,548372.0,24410.0,0.07,IC50,Inhibition of [3H]CPP binding to rat N-methyl-D-aspartate glutamate receptor,Confirmatory,1361582.0,
252,145038,9,5,,103699331,33032,Active,548374.0,24411.0,0.07,IC50,Inhibition of [3H]CPP binding to rat N-methyl-D-aspartate glutamate receptor,Confirmatory,1361582.0,
253,145038,9,5,,103699331,33032,Active,548379.0,24408.0,0.07,IC50,Inhibition of [3H]CPP binding to rat N-methyl-D-aspartate glutamate receptor,Confirmatory,1361582.0,
254,145038,9,5,,103699331,33032,Active,3915771.0,24409.0,0.07,IC50,Inhibition of [3H]CPP binding to rat N-methyl-D-aspartate glutamate receptor,Confirmatory,1361582.0,
255,145038,9,5,,103699331,33032,Active,18202594.0,24412.0,0.07,IC50,Inhibition of [3H]CPP binding to rat N-methyl-D-aspartate glutamate receptor,Confirmatory,1361582.0,
256,145038,9,5,,103699331,33032,Active,51701630.0,170796.0,0.07,IC50,Inhibition of [3H]CPP binding to rat N-methyl-D-aspartate glutamate receptor,Confirmatory,1361582.0,
257,145038,9,5,,103699331,33032,Active,51701631.0,191573.0,0.07,IC50,Inhibition of [3H]CPP binding to rat N-methyl-D-aspartate glutamate receptor,Confirmatory,1361582.0,
258,145250,3,5,,103699331,33032,Inactive,,,,,NMDA Antagonist activity was evaluated; na means no activity,Other,2859375.0,
259,145324,9,2,,103699331,33032,Active,,,0.2,Ki,Binding affinity towards NMDA receptor by displacement of [3H]CGP-39653 radioligand.,Confirmatory,11472204.0,
260,146057,6,2,,103699331,33032,Active,,,1.7,EC50,Effective concentration against NR1/NR2A receptor,Confirmatory,10893301.0,
261,146060,6,2,,103699331,33032,Active,,,0.8,EC50,Effective concentration against NR1/NR2B receptor,Confirmatory,10893301.0,
262,146062,6,2,,103699331,33032,Active,,,0.7,EC50,Effective concentration against NR1/NR2C receptor,Confirmatory,10893301.0,
263,146064,6,2,,103699331,33032,Active,,,0.4,EC50,Effective concentration against NR1/NR2D receptor,Confirmatory,10893301.0,
264,168024,3,3,,103699331,33032,Unspecified,,,,,Protective potency against glutamate-induced neurotoxicity in cultures of embryonic rat brain at a concentration of 100 uM (p < 0.05),Other,10340618.0,
265,168915,8,2,,103699331,33032,Active,,,0.5,IC50,In vitro binding affinity against synaptic membrane from rat brain using [3H]-AMPA as the radioligand,Confirmatory,2552114.0,
266,168917,9,1,,103699331,33032,Active,,,0.27,IC50,In vitro binding affinity against synaptic membrane from rat brain using [3H]KAIN as the radioligand,Confirmatory,2552114.0,
267,175859,8,3,,103699331,33032,Inconclusive,,,,,In vitro stimulation of norepinephrine release from hippocampal nerve endings; Not determined,Other,9379437.0,
268,179581,6,2,,103699331,33032,Active,,,0.17,IC50,In vitro binding affinity against synaptic membrane from rat brain using [3H](S)-Glu as the radioligand,Confirmatory,2552114.0,
269,179948,6,2,,103699331,33032,Active,,,1.3,IC50,Inhibition of [3H]AMPA binding in rat brain membrane was evaluated,Confirmatory,2859375.0,
270,187275,2,4,,103699331,33032,Unspecified,,,,,Compound was evaluated for its depolarizing activity in the isolated rat spinal cord and the relative potency was determined,Other,,
271,187287,3,3,,103699331,33032,Active,,,,,GDEE-sensitive neuronal excitant (Relative potency) was evaluated;,Other,2859375.0,
272,194868,4,3,,103699331,33032,Unspecified,,,,,Effect of pretreatment on the survival of the rat embryonic forebrain neurons when exposed to glutamate,Other,11078202.0,
273,196268,3,3,,103699331,33032,Unspecified,,,,,Depolarizing potency in new born rat spinal cord,Other,8558509.0,
274,196746,7,1,,103699331,33032,Active,,,,,Potential inhibitory activity of EAAT2 by the ability (250 uM) to attenuate the Na-dependent uptake of [3H]D-aspartate (5 uM) into synaptosomes of rat forebrain,Other,12372536.0,
275,212738,3,7,,103699331,33032,Unspecified,,,,,Inhibitory activity against Tetanus neurotoxin (TeNt) light chain by using fluorescent synaptobrevin derivative [Pya88]S 39-88 as substrate at 10e-3 M.,Other,9719598.0,
276,221527,6,4,,103699331,33032,Active,,,0.61,EC50,Agonistic activity evaluated in CHO(Chinese hamster ovary) cells expressing mGluR2 receptor,Confirmatory,10397508.0,
277,221665,6,4,,103699331,33032,Active,,,2.5,EC50,Agonistic activity evaluated in CHO(Chinese hamster ovary) cells expressing chimeric mGluR3/1a receptor,Confirmatory,10397508.0,
278,222323,9,1,,103699331,33032,Active,,,7.4,EC50,Antagonistic activity against stimulation of GTP (gamma) 35 S binding by glutamate in membranes from CHO cells expressing human mGluR2,Confirmatory,11720869.0,
279,224504,4,3,,103699331,33032,Inconclusive,,,,,Effect on rate of GTP hydrolysis in the GTP binding protein ras p21; Not determined,Other,9871712.0,
280,231223,3,7,,103699331,33032,Unspecified,,,,,"Potency at metabotropic glutamate receptor 1, measured as the ratio of EC50 to IC50",Other,12109902.0,
281,231224,3,7,,103699331,33032,Unspecified,,,,,"Potency at metabotropic glutamate receptor 2, measured as the ratio of EC50 to IC50",Other,12109902.0,
282,231225,3,7,,103699331,33032,Unspecified,,,,,"Potency at metabotropic glutamate receptor 4, measured as the ratio of EC50 to IC50",Other,12109902.0,
283,233183,5,1,,103699331,33032,Unspecified,,,,,Ratio of kcat to that of KM was determined,Other,,
284,233320,3,3,,103699331,33032,Unspecified,,,,,Bitter threshold value; NB denotes 'Not bitter',Other,3656360.0,
285,239119,9,5,,103699331,33032,Active,548372.0,24410.0,0.87,Ki,Displacement of L-[3H]glutamate from N-methyl-D-aspartate glutamate receptor in rat brain synaptic membranes,Confirmatory,15837309.0,
286,239119,9,5,,103699331,33032,Active,548374.0,24411.0,0.87,Ki,Displacement of L-[3H]glutamate from N-methyl-D-aspartate glutamate receptor in rat brain synaptic membranes,Confirmatory,15837309.0,
287,239119,9,5,,103699331,33032,Active,548379.0,24408.0,0.87,Ki,Displacement of L-[3H]glutamate from N-methyl-D-aspartate glutamate receptor in rat brain synaptic membranes,Confirmatory,15837309.0,
288,239119,9,5,,103699331,33032,Active,3915771.0,24409.0,0.87,Ki,Displacement of L-[3H]glutamate from N-methyl-D-aspartate glutamate receptor in rat brain synaptic membranes,Confirmatory,15837309.0,
289,239119,9,5,,103699331,33032,Active,18202594.0,24412.0,0.87,Ki,Displacement of L-[3H]glutamate from N-methyl-D-aspartate glutamate receptor in rat brain synaptic membranes,Confirmatory,15837309.0,
290,239119,9,5,,103699331,33032,Active,51701630.0,170796.0,0.87,Ki,Displacement of L-[3H]glutamate from N-methyl-D-aspartate glutamate receptor in rat brain synaptic membranes,Confirmatory,15837309.0,
291,239119,9,5,,103699331,33032,Active,51701631.0,191573.0,0.87,Ki,Displacement of L-[3H]glutamate from N-methyl-D-aspartate glutamate receptor in rat brain synaptic membranes,Confirmatory,15837309.0,
292,242207,9,5,,103699331,33032,Active,12644040.0,2918.0,0.0057,IC50,Inhibitory concentration against [3H]1 binding to recombinant human Metabotropic glutamate receptor 8,Confirmatory,15603952.0,
293,255079,8,5,,103699331,33032,Active,803374855.0,140.0,0.613,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,Confirmatory,16250647.0,
294,257131,8,1,,103699331,33032,Active,1169458.0,6507.0,,Ki,Binding affinity to human EAAT1 expressed in HEK293 cells in FMP (FLPR) assay,Confirmatory,16335922.0,
295,257132,8,1,,103699331,33032,Active,3041668.0,6506.0,,Ki,Binding affinity to human EAAT2 expressed in HEK293 cells in FMP (FLPR) assay,Confirmatory,16335922.0,
296,257133,8,1,,103699331,33032,Active,1352332.0,6505.0,,Ki,Binding affinity to human EAAT3 expressed in HEK293 cells in FMP (FLPR) assay,Confirmatory,16335922.0,
297,257202,11,1,,103699331,33032,Active,3287965.0,54257.0,3.28,Ki,Displacement of [3H]kainate from rat GLUK6 receptor expressed in HEK293 cells,Confirmatory,16302825.0,
298,258675,7,6,,103699331,33032,Active,121300.0,24414.0,7.3,EC50,Activity at rat mGluR1 by measuring intracellular calcium concentration in CHO cells,Confirmatory,16213710.0,
299,258676,6,7,,103699331,33032,Active,1170947.0,24418.0,1.2,EC50,Activity at rat mGluR5 by measuring intracellular calcium concentration in CHO cells,Confirmatory,16213710.0,
300,258677,11,1,,103699331,33032,Active,76803802.0,2912.0,26.0,EC50,Activity at human mGluR2 from BHK cells in [35S]GTP-gamma-S stimulation assay,Confirmatory,16213710.0,
301,258678,6,7,,103699331,33032,Active,400255.0,24417.0,6.1,EC50,Functional activity at rat mGluR4,Confirmatory,16213710.0,
302,258679,7,6,,103699331,33032,Active,547903.0,24419.0,7.6,EC50,Activity at rat mGluR6 by measuring cAMP formation in CHO cells,Confirmatory,16213710.0,
303,258680,7,6,,103699331,33032,Unspecified,2495078.0,2917.0,1000.0,EC50,Activity at human mGluR7 by measuring cAMP formation in BHK cells,Confirmatory,16213710.0,
304,258681,10,5,,103699331,33032,Active,400255.0,24417.0,3.4,Ki,Displacement of [3H]L-AP4 from rat mGluR4 expressed in BHK cells,Confirmatory,16213710.0,
305,258682,9,5,,103699331,33032,Active,2495080.0,60590.0,3.4,Ki,Displacement of [3H]LY341495 from rat mGluR8 expressed in BHK cells,Confirmatory,16213710.0,
306,262621,6,7,,103699331,33032,Active,121434.0,29628.0,0.214,IC50,Antagonist activity against AMPA receptor expressed in motoneurones by inhibition of fDR-VRP in the neonatal rat spinal cord,Confirmatory,16610801.0,
307,262621,6,7,,103699331,33032,Active,121435.0,29629.0,0.214,IC50,Antagonist activity against AMPA receptor expressed in motoneurones by inhibition of fDR-VRP in the neonatal rat spinal cord,Confirmatory,16610801.0,
308,262621,6,7,,103699331,33032,Active,3287964.0,29627.0,0.214,IC50,Antagonist activity against AMPA receptor expressed in motoneurones by inhibition of fDR-VRP in the neonatal rat spinal cord,Confirmatory,16610801.0,
309,262621,6,7,,103699331,33032,Active,97536283.0,50592.0,0.214,IC50,Antagonist activity against AMPA receptor expressed in motoneurones by inhibition of fDR-VRP in the neonatal rat spinal cord,Confirmatory,16610801.0,
310,262622,9,5,,103699331,33032,Active,3287965.0,54257.0,3.28,Ki,Displacement of [3H]kainate from rat GLUK6 expressed in HEK293 cells,Confirmatory,16610801.0,
311,262628,7,6,,103699331,33032,Active,729597.0,2897.0,22.0,EC50,Induction of calcium influx in HEK293 cells expressing human GLUK5 by FLIPR assay,Confirmatory,16610801.0,
312,262629,6,2,,103699331,33032,Active,,,27.0,EC50,Induction of calcium influx in HEK293 cells expressing human GLUK5/GLUK6 by FLIPR assay,Confirmatory,16610801.0,
313,262630,6,2,,103699331,33032,Active,,,35.0,EC50,Induction of calcium influx in HEK293 cells expressing human GLUK5/GLUK2 by FLIPR assay,Confirmatory,16610801.0,
314,271628,6,7,,103699331,33032,Unspecified,1169458.0,6507.0,,Km,Substrate activity at human EAAT1 expressed in HEK293 cells by FLIPR membrane potential assay,Confirmatory,17064071.0,
315,271629,6,7,,103699331,33032,Unspecified,3041668.0,6506.0,,Km,Substrate activity at human EAAT2 expressed in HEK293 cells by FLIPR membrane potential assay,Confirmatory,17064071.0,
316,271630,6,7,,103699331,33032,Unspecified,1352332.0,6505.0,,Km,Substrate activity at human EAAT3 expressed in HEK293 cells by FLIPR membrane potential assay,Confirmatory,17064071.0,
317,291424,9,5,,103699331,33032,Unspecified,548615.0,2346.0,428.0,IC50,Inhibition of human recombinant glutamate carboxypeptidase 2 by radioenzymatic assay,Confirmatory,17567119.0,
318,295059,10,5,,103699331,33032,Active,121300.0,24414.0,7.3,EC50,Activity at rat recombinant mGluR1 expressed in CHO cells assessed as intracellular calcium concentration,Confirmatory,17350267.0,
319,295060,10,5,,103699331,33032,Active,1170947.0,24418.0,1.2,EC50,Activity at rat recombinant mGluR5 expressed in CHO cells assessed as intracellular calcium concentration,Confirmatory,17350267.0,
320,295061,10,1,,103699331,33032,Active,76803802.0,2912.0,26.0,EC50,Activity at human recombinant mGluR2 expressed in BHK cells assessed as stimulation of [35S]GTP-gamma-S binding,Confirmatory,17350267.0,
321,295062,6,7,,103699331,33032,Active,400255.0,24417.0,6.1,EC50,Agonist activity at rat recombinant mGluR4 expressed in BHK cells,Confirmatory,17350267.0,
322,295063,9,5,,103699331,33032,Active,547903.0,24419.0,7.6,EC50,Activity at rat recombinant mGluR6 expressed in CHO cells assessed as cAMP production,Confirmatory,17350267.0,
323,295064,7,6,,103699331,33032,Unspecified,2495078.0,2917.0,1000.0,EC50,Activity at human recombinant mGluR7 expressed in BHK cells assessed as cAMP production,Confirmatory,17350267.0,
324,295065,9,5,,103699331,33032,Active,400255.0,24417.0,3.4,Ki,Displacement of [3H]L-AP4 from rat recombinant mGluR4 expressed in BHK cells by SPA assay,Confirmatory,17350267.0,
325,295066,9,5,,103699331,33032,Active,2495080.0,60590.0,3.4,Ki,Displacement of [3H]LY341495 from rat recombinant mGluR8 expressed in BHK cells by SPA assay,Confirmatory,17350267.0,
326,297345,7,1,,103699331,33032,Unspecified,,,71.0,EC50,Agonist activity at GluR1 expressed in HEK293 cells by Fluo-4/Ca2+ assay,Confirmatory,17672447.0,
327,297347,7,1,,103699331,33032,Unspecified,,,140.0,EC50,Agonist activity at GluR2Q expressed in HEK293 cells by Fluo-4/Ca2+ assay,Confirmatory,17672447.0,
328,297349,7,1,,103699331,33032,Unspecified,,,67.0,EC50,Agonist activity at GluR3 expressed in HEK293 cells by Fluo-4/Ca2+ assay,Confirmatory,17672447.0,
329,297351,7,1,,103699331,33032,Active,,,28.0,EC50,Agonist activity at GluR4 expressed in HEK293 cells by Fluo-4/Ca2+ assay,Confirmatory,17672447.0,
330,297353,7,1,,103699331,33032,Unspecified,,,63.0957,EC50,Agonist activity at GluR1 D399S mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay,Confirmatory,17672447.0,
331,297355,7,1,,103699331,33032,Active,,,39.8107,EC50,Agonist activity at GluR1 E683A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay,Confirmatory,17672447.0,
332,297357,7,1,,103699331,33032,Unspecified,,,63.0957,EC50,Agonist activity at GluR1 M686V mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay,Confirmatory,17672447.0,
333,297359,7,1,,103699331,33032,Unspecified,,,140.0,EC50,Agonist activity at GluR1 I687A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay,Confirmatory,17672447.0,
334,297360,3,4,,103699331,33032,Inconclusive,,,,,Agonist activity at GluR1 D399S/E683A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay,Other,17672447.0,
335,297362,7,1,,103699331,33032,Unspecified,,,76.0,EC50,Agonist activity at GluR1 M686V/I687 mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay,Confirmatory,17672447.0,
336,297364,7,1,,103699331,33032,Unspecified,,,60.0,EC50,Agonist activity at GluR1 D399S/M686V/I687A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay,Confirmatory,17672447.0,
337,297366,7,1,,103699331,33032,Unspecified,,,110.0,EC50,Agonist activity at GluR1 E683A/M686V/I687A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay,Confirmatory,17672447.0,
338,297368,3,4,,103699331,33032,Inconclusive,,,,,Agonist activity at GluR1 D399S/E683A/M686V/I687A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay,Other,17672447.0,
339,298022,9,5,,103699331,33032,Active,311033443.0,2911.0,0.25,Ki,Displacement of [3H]quisqualate from mGluR1 receptor expressed in BHK cells,Confirmatory,17725337.0,
340,298023,10,5,,103699331,33032,Active,76803802.0,2912.0,11.0,Ki,Displacement of [3H]LY341495 from mGluR2 receptor expressed in BHK cells,Confirmatory,17725337.0,
341,298024,10,5,,103699331,33032,Active,1709020.0,2915.0,0.39,Ki,Binding affinity to mGluR5 receptor expressed in BHK cells,Confirmatory,17725337.0,
342,298025,9,5,,103699331,33032,Active,2495077.0,2914.0,2.4,Ki,Displacement of [3H]LAP4 from mGluR4 receptor expressed in BHK cells,Confirmatory,17725337.0,
343,298026,6,2,,103699331,33032,Active,,,0.2,Ki,Displacement of [3H]CGP-39653 from rat NMDA receptor expressed in BHK cells,Confirmatory,17725337.0,
344,298027,6,2,,103699331,33032,Active,,,0.07,Ki,Displacement of [3H]kainic acid from rat KA receptor expressed in BHK cells,Confirmatory,17725337.0,
345,298028,6,2,,103699331,33032,Active,,,0.08,Ki,Displacement of [3H]AMPA from rat AMPA receptor expressed in BHK cells,Confirmatory,17725337.0,
346,319175,10,1,,103699331,33032,Active,97536283.0,50592.0,35.0,EC50,Activity at rat cloned iGluR1 expressed in human HEK293 cells by calcium imaging assay,Confirmatory,18338843.0,
347,319177,7,1,,103699331,33032,Unspecified,3287964.0,29627.0,140.0,EC50,Activity at rat cloned iGluR2 expressed in human HEK293 cells by calcium imaging assay,Confirmatory,18338843.0,
348,319179,10,1,,103699331,33032,Unspecified,121434.0,29628.0,100.0,EC50,Activity at rat cloned iGluR3 expressed in human HEK293 cells by calcium imaging assay,Confirmatory,18338843.0,
349,319181,10,1,,103699331,33032,Active,121435.0,29629.0,17.0,EC50,Activity at rat cloned iGluR4 expressed in human HEK293 cells by calcium imaging assay,Confirmatory,18338843.0,
350,319183,7,1,,103699331,33032,Unspecified,1169962.0,29559.0,130.0,EC50,Activity at rat cloned iGluR5 expressed in human HEK293 cells by calcium imaging assay,Confirmatory,18338843.0,
351,319185,10,1,,103699331,33032,Unspecified,3287965.0,54257.0,66.0,EC50,Activity at rat cloned iGluR6 expressed in human HEK293 cells by calcium imaging assay,Confirmatory,18338843.0,
352,327308,7,1,,103699331,33032,Unspecified,2492984.0,900031.0,,Km,Activity of Helicobacter pylori MurI,Confirmatory,17568739.0,
353,327309,7,1,,103699331,33032,Unspecified,,,,Km,Activity of Helicobacter pylori MurI A75T mutant,Confirmatory,17568739.0,
354,327310,7,1,,103699331,33032,Unspecified,,,,Km,Activity of Helicobacter pylori MurI E151K mutant,Confirmatory,17568739.0,
355,327311,7,1,,103699331,33032,Unspecified,,,,Km,Activity of Escherichia coli MurI,Confirmatory,17568739.0,
356,327312,7,1,,103699331,33032,Unspecified,81585411.0,1200023.0,,Km,Activity of Enterococcus faecalis MurI,Confirmatory,17568739.0,
357,327313,7,1,,103699331,33032,Unspecified,,,,Km,Activity of Enterococcus faecium MurI,Confirmatory,17568739.0,
358,327314,7,1,,103699331,33032,Unspecified,,,,Km,Activity of Staphylococcus aureus MurI,Confirmatory,17568739.0,
359,328866,6,2,,103699331,33032,Unspecified,,,122.0,Kd,Binding affinity to Pyrococcus horikoshii sodium-coupled aspartate transporter,Confirmatory,17230192.0,
360,339877,6,3,,103699331,33032,Active,,,0.34,IC50,Displacement of [3H]AMPA from AMPA receptor in rat cortical synaptosome,Confirmatory,18578474.0,
361,339878,6,3,,103699331,33032,Active,,,0.38,IC50,Displacement of [3H]KAIN from KA receptor in rat cortical synaptosome,Confirmatory,18578474.0,
362,339879,6,3,,103699331,33032,Active,,,0.2,Ki,Displacement of [3H]CGP39653 from NMDA receptor in rat cortical synaptosome,Confirmatory,18578474.0,
363,339880,10,5,,103699331,33032,Active,548379.0,24408.0,2.9,EC50,Activity at rat recombinant NR1/NR2A receptor expressed in Xenopus oocytes assessed as effect on glutamate-induced current by two voltage clamp electrophysiology,Confirmatory,18578474.0,
364,339882,9,5,,103699331,33032,Active,548379.0,24408.0,1.8,EC50,Activity at rat recombinant NR1/NR2B receptor expressed in Xenopus oocytes assessed as effect on glutamate-induced current by two voltage clamp electrophysiology,Confirmatory,18578474.0,
365,339883,10,5,,103699331,33032,Active,548379.0,24408.0,0.45,EC50,Activity at rat NR1/NR2D receptor expressed in Xenopus oocytes assessed as effect on glutamate-induced current by two voltage clamp electrophysiology,Confirmatory,18578474.0,
366,339885,10,5,,103699331,33032,Active,548379.0,24408.0,1.0,EC50,Activity at rat recombinant NR1/NR2C receptor expressed in Xenopus oocytes assessed as effect on glutamate-induced current by two voltage clamp electrophysiology,Confirmatory,18578474.0,
367,339907,10,5,,103699331,33032,Active,1169458.0,6507.0,,Ki,Inhibition of [3H]D-Asp uptake at EAAT1 in HEK293 cells,Confirmatory,18578477.0,
368,339908,11,5,,103699331,33032,Unspecified,3041668.0,6506.0,62.0,Ki,Inhibition of [3H]D-Asp uptake at human EAAT2 in HEK293 cells,Confirmatory,18578477.0,
369,339909,10,5,,103699331,33032,Active,1352332.0,6505.0,,Ki,Inhibition of [3H]D-Asp uptake at human EAAT3 in HEK293 cells,Confirmatory,18578477.0,
370,339927,11,2,,103699331,33032,Active,1169962.0,29559.0,0.14,Ki,Displacement of [3H]SYM2081 from rat recombinant iGluR5,Confirmatory,18578478.0,
371,339928,12,2,,103699331,33032,Active,3287965.0,54257.0,0.331,Ki,Displacement of [3H]SYM2081 from rat recombinant iGluR6,Confirmatory,18578478.0,
372,339929,12,2,,103699331,33032,Active,1169965.0,298521.0,0.494,Ki,Displacement of [3H]SYM2081 from rat recombinant iGluR7,Confirmatory,18578478.0,
373,355928,4,3,,103699331,33032,Active,,,0.069,IC50,Displacement of [3H]CGP39653 from NMDA receptor in Sprague-Dawley rat brain membrane,Confirmatory,12828462.0,
374,391442,8,5,,103699331,33032,Active,97536283.0,50592.0,0.16899999999999998,Ki,"Displacement of (R,S)-[5-methyl-3H]AMPA from rat recombinant flop iGluR1 expressed in Sf9 cells",Confirmatory,18811139.0,
375,391443,8,5,,103699331,33032,Active,3287964.0,29627.0,0.282,Ki,"Displacement of (R,S)-[5-methyl-3H]AMPA from rat recombinant flop iGluR2(R) expressed in Sf9 cells",Confirmatory,18811139.0,
376,391444,9,5,,103699331,33032,Active,121434.0,29628.0,0.249,Ki,"Displacement of (R,S)-[5-methyl-3H]AMPA from rat recombinant flop iGluR3 expressed in Sf9 cells",Confirmatory,18811139.0,
377,391445,9,5,,103699331,33032,Active,121435.0,29629.0,0.354,Ki,"Displacement of (R,S)-[5-methyl-3H]AMPA from rat recombinant flop iGluR4 expressed in Sf9 cells",Confirmatory,18811139.0,
378,391446,12,2,,103699331,33032,Active,1169962.0,29559.0,,IC50,Displacement of [3H]SYM2081 from rat recombinant iGluR5(Q)1b expressed in Sf9 cells,Confirmatory,18811139.0,
379,391447,11,2,,103699331,33032,Active,3287965.0,54257.0,0.332,Ki,"Displacement of [3H]kainic acid from rat recombinant iGluR6(V,C,R) receptor expressed in Sf9 cells",Confirmatory,18811139.0,
380,411486,9,1,,103699331,33032,Active,,,0.29,Ki,Displacement of [3H]CGP39653 from NMDA receptor in rat brain membranes,Confirmatory,19042134.0,
381,411487,6,3,,103699331,33032,Active,,,0.17,Ki,Displacement of [3H]AMPA from AMPA receptor in rat brain membranes,Confirmatory,19042134.0,
382,411488,6,3,,103699331,33032,Active,,,0.092,Ki,Displacement of [3H]kainic acid from kainate receptor in rat brain membranes,Confirmatory,19042134.0,
383,411489,10,5,,103699331,33032,Active,311033443.0,2911.0,0.57,Ki,Displacement of [3H]Quisqualate from human mGluR1A receptor expressed in BHK cells,Confirmatory,19042134.0,
384,411490,10,5,,103699331,33032,Active,1709020.0,2915.0,1.16,Ki,Displacement of [3H]Quisqualate from human mGluR5 receptor expressed in BHK cells,Confirmatory,19042134.0,
385,411491,10,5,,103699331,33032,Active,76803802.0,2912.0,6.4,Ki,Displacement of [3H]Quisqualate from human mGluR2 receptor expressed in BHK cells,Confirmatory,19042134.0,
386,411492,10,5,,103699331,33032,Active,2495077.0,2914.0,1.4,Ki,Displacement of [3H]Quisqualate from human mGluR4 receptor expressed in BHK cells,Confirmatory,19042134.0,
387,422606,9,2,,103699331,33032,Unspecified,97536283.0,50592.0,51.0,EC50,Agonist activity at rat recombinant GluR1 flip isoform expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay,Confirmatory,19588945.0,
388,422608,9,2,,103699331,33032,Unspecified,3287964.0,29627.0,190.0,EC50,Agonist activity at rat recombinant GluR2(Q) RNA-edited isoform expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay,Confirmatory,19588945.0,
389,422610,9,2,,103699331,33032,Unspecified,121434.0,29628.0,52.0,EC50,Agonist activity at rat recombinant GluR3 flip isomer expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay,Confirmatory,19588945.0,
390,422612,9,2,,103699331,33032,Active,121435.0,29629.0,20.0,EC50,Agonist activity at rat recombinant GluR4 flip isomer expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay,Confirmatory,19588945.0,
391,422614,9,2,,103699331,33032,Unspecified,1169962.0,29559.0,140.0,EC50,Agonist activity at rat recombinant GluR5(Q) RNA-edited isoform expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay,Confirmatory,19588945.0,
392,422616,9,2,,103699331,33032,Unspecified,3287965.0,54257.0,73.0,EC50,Agonist activity at rat recombinant GluR6(Q) RNA-edited isoform expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay,Confirmatory,19588945.0,
393,439882,5,3,,103699331,33032,Unspecified,,,631.0,EC50,Agonist activity at recombinant GluR5,Confirmatory,19819046.0,
394,439883,5,3,,103699331,33032,Unspecified,,,270.0,EC50,Agonist activity at recombinant GluR6,Confirmatory,19819046.0,
395,463106,1,2,,90340902,33032,Inactive,188528692.0,9099.0,,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
396,477117,5,7,,103699331,33032,Active,97536283.0,50592.0,6.4,EC50,Agonist activity at rat recombinant GluA1 receptor flop isoform expressed in Xenopus oocytes,Confirmatory,20096591.0,
397,477118,5,7,,103699331,33032,Active,121434.0,29628.0,1.3,EC50,Agonist activity at rat recombinant GluA3 receptor flop isoform expressed in Xenopus oocytes,Confirmatory,20096591.0,
398,477119,5,4,,103699331,33032,Active,,,22.0,EC50,Agonist activity at recombinant GluA1 receptor flop isoform expressed in Xenopus oocytes,Confirmatory,20096591.0,
399,477120,5,4,,103699331,33032,Active,,,6.2,EC50,Agonist activity at recombinant GluA2 receptor flop isoform expressed in Xenopus oocytes,Confirmatory,20096591.0,
400,477121,5,4,,103699331,33032,Active,,,35.0,EC50,Agonist activity at recombinant GluA3 receptor flop isoform expressed in Xenopus oocytes,Confirmatory,20096591.0,
401,477122,5,3,,103699331,33032,Active,,,18.0,EC50,Agonist activity at recombinant GluA1A2 receptor flop isoform expressed in Xenopus oocytes,Confirmatory,20096591.0,
402,477123,5,3,,103699331,33032,Active,,,11.0,EC50,Agonist activity at recombinant GluA2A3 receptor flop isoform expressed in Xenopus oocytes,Confirmatory,20096591.0,
403,477124,5,3,,103699331,33032,Active,,,8.1,EC50,Agonist activity at recombinant GluA4 receptor flop isoform expressed in Xenopus oocytes,Confirmatory,20096591.0,
404,477125,5,3,,103699331,33032,Active,,,3.5,EC50,Agonist activity at recombinant GluA2A4 receptor flop isoform expressed in Xenopus oocytes,Confirmatory,20096591.0,
405,477138,5,7,,103699331,33032,Unspecified,97536283.0,50592.0,51.0,EC50,Agonist activity at rat recombinant GluA1 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay,Confirmatory,20096591.0,
406,477139,5,7,,103699331,33032,Unspecified,3287964.0,29627.0,190.0,EC50,Agonist activity at rat recombinant GluA2 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay,Confirmatory,20096591.0,
407,477140,5,7,,103699331,33032,Unspecified,121434.0,29628.0,52.0,EC50,Agonist activity at rat recombinant GluA3 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay,Confirmatory,20096591.0,
408,477141,5,7,,103699331,33032,Active,121435.0,29629.0,20.0,EC50,Agonist activity at rat recombinant GluA4 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay,Confirmatory,20096591.0,
409,477146,5,3,,103699331,33032,Active,,,6.16,EC50,Agonist activity at recombinant GluA1A2 receptor flip isoform expressed in Xenopus oocytes,Confirmatory,20096591.0,
410,477147,5,3,,103699331,33032,Active,,,32.3,EC50,Agonist activity at recombinant GluA2A4 receptor flip isoform expressed in Xenopus oocytes,Confirmatory,20096591.0,
411,477557,5,4,,103699331,33032,Active,,,2.26,EC50,Agonist activity at recombinant GluA1 receptor flip isoform expressed in Xenopus oocytes co-expressing gamma2-TARP,Confirmatory,20096591.0,
412,477558,5,4,,103699331,33032,Active,,,2.19,EC50,Agonist activity at recombinant GluA2 receptor flop isoform expressed in Xenopus oocytes co-expressing gamma2-TARP,Confirmatory,20096591.0,
413,477559,5,4,,103699331,33032,Active,,,3.66,EC50,Agonist activity at recombinant GluA3 receptor flop isoform expressed in Xenopus oocytes co-expressing gamma2-TARP,Confirmatory,20096591.0,
414,477560,5,3,,103699331,33032,Active,,,2.75,EC50,Agonist activity at recombinant GluA4 receptor flop isoform expressed in Xenopus oocytes co-expressing gamma2-TARP,Confirmatory,20096591.0,
415,478462,6,1,,103699331,33032,Active,,,0.34,IC50,Displacement of [3H]AMPA from AMPA receptor in Sprague-Dawley rat brain membranes,Confirmatory,20408529.0,
416,478463,6,1,,103699331,33032,Active,,,0.38,IC50,Displacement of [3H]KA from KA receptor in Sprague-Dawley rat brain membranes,Confirmatory,20408529.0,
417,478464,6,1,,103699331,33032,Active,,,0.2,Ki,Displacement of [3H]CGP39653 from NMDA receptor in Sprague-Dawley rat brain membranes,Confirmatory,20408529.0,
418,478466,10,1,,103699331,33032,Active,3287964.0,29627.0,0.28,Ki,Displacement of [3H]AMPA from rat iGluR2 receptor expressed in Sf9 cells baculovirus system after 1 to 2 hrs by liquid scintillation counting,Confirmatory,20408529.0,
419,478467,10,1,,103699331,33032,Active,1169962.0,29559.0,0.14,Ki,Displacement of [3H]SYM2081 from rat iGluR5 receptor expressed in Sf9 cells baculovirus system after 1 to 2 hrs by liquid scintillation counting,Confirmatory,20408529.0,
420,478468,10,1,,103699331,33032,Active,3287965.0,54257.0,0.33,Ki,Displacement of [3H]SYM2081 from rat iGluR6 receptor expressed in Sf9 cells baculovirus system after 1 to 2 hrs by liquid scintillation counting,Confirmatory,20408529.0,
421,478469,10,1,,103699331,33032,Active,1169965.0,298521.0,0.49,Ki,Displacement of [3H]SYM2081 from rat iGluR7 receptor expressed in Sf9 cells baculovirus system after 1 to 2 hrs by liquid scintillation counting,Confirmatory,20408529.0,
422,478471,9,1,,103699331,33032,Active,,,14.0,EC50,Activity at recombinant iGluR2 receptor expressed in Xenopus laevis oocytes using holding potential of -15 to -20 mV by TEVC electrophysiology,Confirmatory,20408529.0,
423,478473,6,1,,103699331,33032,Active,548379.0,24408.0,,EC50,Agonist activity at rat NR1/NR2A receptor expressed in BHK21 cells assessed as change in intracellular calcium levels by FLIPR assay,Confirmatory,20408529.0,
424,478473,6,1,,103699331,33032,Active,3915771.0,24409.0,,EC50,Agonist activity at rat NR1/NR2A receptor expressed in BHK21 cells assessed as change in intracellular calcium levels by FLIPR assay,Confirmatory,20408529.0,
425,485281,1,1,,26751652,33032,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
426,485290,1,1,,11113412,33032,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
427,485290,1,1,,26751652,33032,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
428,485295,1,2,,90340902,33032,Inactive,30027657.0,,,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
429,485297,1,1,,90340902,33032,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
430,485298,1,1,,90340902,33032,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
431,485313,1,2,,90340902,33032,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
432,485342,1,2,,90340902,33032,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
433,485345,1,2,,90340902,33032,Inactive,,,,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
434,485366,1,2,,90340902,33032,Inconclusive,4501969.0,154.0,20.5962,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
435,485368,1,2,,90340902,33032,Inactive,72386991.0,3656265.0,,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
436,488772,1,1,,90340902,33032,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
437,488773,1,2,,90340902,33032,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
438,488816,1,1,,90340902,33032,Inactive,4758356.0,2237.0,,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
439,488837,1,1,,90340902,33032,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
440,488949,1,2,,90340902,33032,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
441,488953,1,1,,90340902,33032,Inactive,187960037.0,10951.0,,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
442,488978,1,1,,90340902,33032,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
443,488981,1,1,,90340902,33032,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
444,488982,1,1,,90340902,33032,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
445,488983,1,1,,90340902,33032,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
446,493106,1,1,,90340902,33032,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
447,493107,1,1,,90340902,33032,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
448,493153,1,1,,90340902,33032,Inactive,,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
449,493153,1,1,,90340902,33032,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
450,493164,1,2,,90340902,33032,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
451,493164,1,2,,90340902,33032,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
452,493164,1,2,,90340902,33032,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
453,500825,2,3,,103699331,33032,Active,,,,,Induction of nitrogen-starved wild type sigma1278b yeast Gap1-mediated trehalose activation at 10 mM,Other,19060912.0,
454,502881,2,3,,103699331,33032,Active,,,,,Binding affinity to Glutamate receptor 2 E705D mutant S1S2 ligand binding domain assessed as induction protein vibrational state by time resolved FTIR difference spectra method,Other,16408071.0,
455,502882,2,3,,103699331,33032,Active,,,,,Binding affinity to Glutamate receptor 2 Y450F mutant S1S2 ligand binding domain assessed as induction protein vibrational state by time resolved FTIR difference spectra method,Other,16408071.0,
456,502883,2,8,,103699331,33032,Active,,,,,Binding affinity to wild type Glutamate receptor 2 S1S2 ligand binding domain assessed as induction protein vibrational state by time resolved FTIR difference spectra method,Other,16408071.0,
457,503016,2,5,,103699331,33032,Active,,,,,Agonist activity at iGluR6 L439C mutant expressed in human HEK293 cells assessed as increase in intracellular Ca2+ levels at 1 mM by FURA-2-M staining based fluorimetric method,Other,16408092.0,
458,503019,2,5,,103699331,33032,Active,,,,,Agonist activity at MAG conjugated light activated iGluR6 L439C mutant expressed in human HEK293 cells assessed as increase inward currents by whole cell patch clamp method,Other,16408092.0,
459,503020,2,5,,103699331,33032,Active,,,,,Agonist activity at MAG conjugated light activated iGluR6 L439C mutant expressed in human HEK293 cells assessed as increase inward currents illuminated at 380 nm wavelength by whole cell patch clamp method,Other,16408092.0,
460,503021,2,5,,103699331,33032,Inactive,,,,,Agonist activity at MAG conjugated light activated iGluR6 L439C mutant expressed in human HEK293 cells assessed as increase inward currents illuminated at 500 nm wavelength by whole cell patch clamp method,Other,16408092.0,
461,503022,2,5,,103699331,33032,Active,,,,,Agonist activity at MAG conjugated light activated iGluR6 L439C mutant expressed in human HEK293 cells assessed as increase inward currents at 300 uM by whole cell patch clamp method,Other,16408092.0,
462,503023,2,5,,103699331,33032,Active,,,,,Agonist activity at MAG conjugated light activated iGluR6 L439C mutant expressed in human HEK293 cells assessed as increase inward currents at =>1 mM by whole cell patch clamp method,Other,16408092.0,
463,504327,1,1,,11113412,33032,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
464,504327,1,1,,26751652,33032,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
465,504327,1,1,,90340902,33032,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
466,504332,1,1,,26751652,33032,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
467,504332,1,1,,90340902,33032,Active,168985070.0,,10.6213,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
468,504536,1,1,,90340902,33032,Inconclusive,5453898.0,5300.0,8.4921,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
469,504547,1,1,,90340902,33032,Inactive,115503961.0,4357161.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
470,504548,1,2,,90340902,33032,Inactive,157877932.0,5655980.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
471,504810,1,2,,90340902,33032,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
472,504812,1,2,,90340902,33032,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
473,504836,1,2,,90340902,33032,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
474,504845,1,1,,11113412,33032,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
475,504845,1,1,,26751652,33032,Inconclusive,86301163.0,5999.0,0.006,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
476,504845,1,1,,90340902,33032,Inactive,86301163.0,5999.0,0.0336,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
477,504847,1,1,,11113412,33032,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
478,504847,1,1,,26751652,33032,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
479,504847,1,1,,90340902,33032,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
480,504865,1,1,,11113412,33032,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
481,504865,1,1,,90340902,33032,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
482,540256,1,2,,90340902,33032,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
483,540276,1,2,,11113412,33032,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
484,540276,1,2,,26751652,33032,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
485,540276,1,2,,50104343,33032,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
486,540276,1,2,,90340902,33032,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
487,566255,2,4,,103699331,33032,Active,,,1.06,IC50,Inhibition of rat AMPA receptor,Confirmatory,20875743.0,
488,569552,5,5,,103699331,33032,Active,76803802.0,2912.0,12.5893,EC50,Agonist activity at human mGluR2 expressed in CHO cells at by [S35]GTPgammaS binding assay,Confirmatory,21232953.0,
489,588211,2,3,,103699331,33032,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",Other,20014752.0,
490,588212,2,3,,103699331,33032,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",Other,20014752.0,
491,588213,2,3,,103699331,33032,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",Other,20014752.0,
492,588349,1,1,,90340902,33032,Inactive,,,,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
493,588378,1,1,,90340902,33032,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
494,588379,1,2,,11113412,33032,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
495,588453,1,1,,90340902,33032,Inactive,8659577.0,58819.0,7.0795,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
496,588456,1,1,,90340902,33032,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
497,588579,1,1,,11113412,33032,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
498,588579,1,1,,26751652,33032,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
499,588579,1,1,,90340902,33032,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
500,588795,1,1,,90340902,33032,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
501,602332,1,1,,11113412,33032,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
502,602332,1,1,,26751652,33032,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
503,602332,1,1,,90340902,33032,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
504,611782,3,3,,103699331,33032,Unspecified,,,108.0,EC50,Agonist activity at rat GluK2 mutant expressed in Xenopus oocytes by two-electrode voltage-clamp electrophysiology,Confirmatory,21619066.0,
505,611783,3,3,,103699331,33032,Unspecified,,,9030.0,EC50,Agonist activity at non-desensitized homomeric rat GluK3 mutant expressed in Xenopus oocytes by two-electrode voltage-clamp electrophysiology,Confirmatory,21619066.0,
506,611784,1,4,,103699331,33032,Unspecified,,,,,Agonist activity at rat GluK2 mutant expressed in Xenopus oocytes at 1 mM by two-electrode voltage-clamp electrophysiology,Other,21619066.0,
507,611791,3,3,,103699331,33032,Unspecified,,,83.5,EC50,Agonist activity at Non-desensitized homomeric rat GluK1(Q)1b mutant expressed in Xenopus oocytes by two-electrode voltage-clamp electrophysiology,Confirmatory,21619066.0,
508,611792,1,4,,103699331,33032,Unspecified,,,,,Agonist activity at Non-desensitized homomeric rat GluK1(Q)1b mutant expressed in Xenopus oocytes at 1 mM by two-electrode voltage-clamp electrophysiology,Other,21619066.0,
509,611795,1,4,,103699331,33032,Unspecified,,,,,Agonist activity at non-desensitized homomeric rat GluK3 mutant expressed in Xenopus oocytes at 1 mM by two-electrode voltage-clamp electrophysiology,Other,21619066.0,
510,617311,7,5,,103699331,33032,Unspecified,14916998.0,2936.0,53.7,IC50,Inhibition of human erythrocyte Glutathione reductase,Confirmatory,21795044.0,
511,617312,7,5,,103699331,33032,Active,14916998.0,2936.0,42.7,Ki,Competitive inhibition of human erythrocyte Glutathione reductase using GSSG substrate by Lineweaver-Burk plot analysis,Confirmatory,21795044.0,
512,624030,1,2,,26751652,33032,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
513,624146,1,1,,90340902,33032,Inactive,71051501.0,2744.0,12.5893,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
514,624147,1,1,,90340902,33032,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
515,624148,1,2,,90340902,33032,Inconclusive,1724069.0,2740.0,9.2,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
516,624149,1,1,,90340902,33032,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
517,624170,1,1,,26751652,33032,Inconclusive,71051501.0,2744.0,12.5893,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
518,624172,1,1,,26751652,33032,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
519,624173,1,3,,26751652,33032,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
520,624455,1,1,,90340902,33032,Inactive,299681.0,1812.0,,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
521,651631,4,1,,144206604,33032,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
522,651632,4,1,,144206604,33032,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
523,651633,4,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
524,651634,4,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
525,651635,1,3,,90340902,33032,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
526,652048,1,2,,144206604,33032,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
527,652051,1,1,,144206604,33032,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
528,652106,1,1,,90340902,33032,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
529,671510,3,6,,103699331,33032,Active,400255.0,24417.0,2.88,EC50,Agonist activity at rat mGlu4 receptor expressed in HEK293 cells coexpressing Gq/Gi and EAAC1 assessed as intracellular calcium production measured every 1.5 secs for 60 secs by Fluo-4-AM based fluorometry,Confirmatory,22750138.0,
530,679723,1,7,,103699331,33032,Unspecified,1709076.0,25027.0,,,TP_TRANSPORTER: uptake of Glutamic acid at a concentration of 0.01uM in MCT1-expressing MDA-MB231 cells,Other,10579682.0,
531,681113,3,6,,103699331,33032,Unspecified,81871541.0,170566.0,,Ki,TP_TRANSPORTER: inhibition of L-tryptophan uptake in Xenopus laevis oocytes,Confirmatory,11278508.0,
532,681145,2,7,,103699331,33032,Unspecified,121945115.0,,,Km,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Confirmatory,11827462.0,
533,686978,1,1,,11113412,33032,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
534,686978,1,1,,144206604,33032,Inconclusive,79154014.0,55775.0,14.581,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
535,686979,1,1,,11113412,33032,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
536,686979,1,1,,144206604,33032,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
537,711557,4,1,,103699331,33032,Active,,,0.07,IC50,Antagonist activity at NMDA receptor (unknwon origin),Confirmatory,21413808.0,
538,720516,2,1,,144206604,33032,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
539,720532,1,1,,11113412,33032,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
540,720532,1,1,,144206604,33032,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
541,720533,1,1,,11113412,33032,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
542,720533,1,1,,144206604,33032,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
543,720538,1,2,,90340902,33032,Inactive,220983390.0,410.0,,Potency,qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay,Confirmatory,,
544,720552,2,1,,144206604,33032,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
545,720559,1,2,,90340902,33032,Inactive,112927.0,351.0,,Potency,qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay,Confirmatory,,
546,720572,1,2,,90340902,33032,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter),Confirmatory,,
547,720573,1,2,,90340902,33032,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter),Confirmatory,,
548,720579,2,1,,144206604,33032,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
549,720580,1,1,,144206604,33032,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
550,720634,2,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
551,720635,2,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
552,720637,2,1,,144206604,33032,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
553,720674,2,2,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
554,720675,2,2,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
555,720678,2,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
556,720679,2,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
557,720680,2,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
558,720681,2,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
559,720682,2,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
560,720683,2,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
561,720684,2,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
562,720685,2,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
563,720686,2,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
564,720687,2,2,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
565,720691,4,1,,144206604,33032,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
566,720692,3,1,,144206604,33032,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
567,720693,3,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
568,720719,2,1,,144206604,33032,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
569,720725,2,1,,144206604,33032,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
570,723866,2,5,,103699331,33032,Active,121434.0,29628.0,0.5,Ki,Binding affinity to full length rat GluA3,Confirmatory,23414088.0,
571,723867,4,2,,103699331,33032,Active,121434.0,29628.0,7.4,Ki,Binding affinity to rat GluA3-LBD (GluK3-S1S2),Confirmatory,23414088.0,
572,723872,2,5,,103699331,33032,Active,1169965.0,298521.0,0.494,Ki,"Displacement of [3H]-(2S,4R)-4-methylglutamic acid from full length recombinant rat GluK3 receptor expressed in sf9 cells by liquid scintillation counting",Confirmatory,23414088.0,
573,723873,2,5,,103699331,33032,Active,3287965.0,54257.0,0.331,Ki,"Displacement of [3H]-(2S,4R)-4-methylglutamic acid from full length recombinant rat GluKK2(VCR) receptor expressed in sf9 cells by liquid scintillation counting",Confirmatory,23414088.0,
574,723874,2,5,,103699331,33032,Active,1169962.0,29559.0,0.14,Ki,"Displacement of [3H]-(2S,4R)-4-methylglutamic acid from full length recombinant rat GluKK1(Q)1b receptor expressed in sf9 cells by liquid scintillation counting",Confirmatory,23414088.0,
575,723875,2,5,,103699331,33032,Active,3287964.0,29627.0,0.282,Ki,Displacement of [3H]AMPA from full length recombinant rat GluKA2(R) receptor expressed in sf9 cells by liquid scintillation counting,Confirmatory,23414088.0,
576,723876,4,1,,103699331,33032,Active,,,0.2,Ki,Displacement of [3H]CGP39653 from NMDA receptor in rat brain cortex after 60 mins by Packard TopCount microplate scintillator counting,Confirmatory,23414088.0,
577,723877,4,1,,103699331,33032,Active,,,0.38,IC50,Displacement of [3H]KA from kainate receptor in rat brain cortex after 60 mins by Packard TopCount microplate scintillator counting,Confirmatory,23414088.0,
578,723878,4,1,,103699331,33032,Active,,,0.34,IC50,Displacement of [3H]AMPA from AMPA receptor in rat brain cortex after 30 mins by Packard TopCount microplate scintillator counting,Confirmatory,23414088.0,
579,733540,1,6,,103699331,33032,Inactive,112817.0,25187.0,,,Displacement of [125I]-N-(p-I-Bn)-THAZ from 5HT2C in rat cerebral cortex membrane at 300 uM after 1 hr by scintillation counting analysis,Other,23301527.0,
580,734755,4,2,,103699331,33032,Unspecified,148841515.0,79068.0,1000.0,IC50,Inhibition of human hexahistidine-tagged full-length FTO expressed in Escherichia coli BL21 (DE3) using 3-methylthymidine as substrate assessed as inhibition of 3-methylthymidine conversion to thymidine after 1 hr by liquid chromatographic analysis,Confirmatory,23547775.0,
581,743012,3,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
582,743014,3,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
583,743015,3,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
584,743033,3,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
585,743035,2,1,,144206604,33032,Inconclusive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
586,743036,2,1,,144206604,33032,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
587,743040,3,1,,144206604,33032,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
588,743041,3,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
589,743042,3,1,,144206604,33032,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
590,743053,2,1,,144206604,33032,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
591,743054,2,1,,144206604,33032,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
592,743063,2,1,,144206604,33032,Inconclusive,124375976.0,367.0,26.8325,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
593,743064,3,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
594,743065,3,1,,144206604,33032,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
595,743066,3,1,,144206604,33032,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
596,743067,2,1,,144206604,33032,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
597,743069,2,1,,144206604,33032,Inconclusive,348019627.0,2099.0,30.1065,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
598,743074,2,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
599,743075,2,1,,144206604,33032,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
600,743077,2,1,,144206604,33032,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
601,743078,2,1,,144206604,33032,Inconclusive,348019627.0,2099.0,28.4224,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
602,743079,3,1,,144206604,33032,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
603,743080,3,1,,144206604,33032,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
604,743081,3,1,,144206604,33032,Inconclusive,,,2.371,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
605,743083,3,1,,144206604,33032,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
606,743084,3,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
607,743085,3,1,,144206604,33032,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
608,743086,3,1,,144206604,33032,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
609,743091,2,1,,144206604,33032,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
610,743094,3,1,,144206604,33032,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
611,743122,2,1,,144206604,33032,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
612,743139,2,1,,144206604,33032,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
613,743140,2,1,,144206604,33032,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
614,743205,1,1,,90340902,33032,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
615,743205,1,1,,90340902,33032,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
616,743206,1,1,,90340902,33032,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
617,743206,1,1,,90340902,33032,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
618,743207,1,1,,90340902,33032,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
619,743207,1,1,,90340902,33032,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
620,743244,1,1,,90340902,33032,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
621,743244,1,1,,144206604,33032,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
622,751675,1,1,,103699331,33032,Active,,,0.24,IC50,Displacement of [3H]Kainic acid from kainate receptor in Wistar rat brain after 60 mins,Confirmatory,23403082.0,
623,751676,1,1,,103699331,33032,Active,,,0.41,IC50,Displacement of [3H]CGP 39653 from NMDA receptor agonist binding site in Wistar rat cerebral cortex after 20 mins,Confirmatory,23403082.0,
624,751740,1,1,,103699331,33032,Unspecified,,,,,Displacement of [3H]CGP39653 from NMDA receptor agonist binding site in Wistar rat cerebral cortex at 10 uM after 20 mins relative to control,Other,23403082.0,
625,751741,1,1,,103699331,33032,Unspecified,,,,,Displacement of [3H]Kainic acid from kainate receptor in Wistar rat brain at 10 uM after 60 mins relative to control,Other,23403082.0,
626,977608,3,1,,46391925,33032,Active,11514178.0,,0.821,IC50,Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB,Other,11086992.0,
627,977610,3,1,,46393547,33032,Active,55670838.0,,15.0,Ki,Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB,Other,8805567.0,
628,977611,3,1,,46392220,33032,Active,15988294.0,,0.24,Kd,Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB,Other,11518533.0,
629,1092307,1,1,,103699331,33032,Unspecified,,,,,Herbicidal activity against Vicia faba assessed as 1 mM of L-[3H]theronine uptake in leaf at 10 mM after 1 hr by liquid scintillation counting analysis relative to untreated control,Other,9305806.0,
630,1092308,1,1,,103699331,33032,Unspecified,,,,,Herbicidal activity against Vicia faba assessed as 1 mM of L-[3H]theronine uptake in leaf at 5 mM after 1 hr by liquid scintillation counting analysis relative to untreated control,Other,9305806.0,
631,1092309,1,1,,103699331,33032,Unspecified,,,,,Herbicidal activity against Vicia faba assessed as 1 mM of L-[3H]theronine uptake in leaf at 1 mM after 1 hr by liquid scintillation counting analysis relative to untreated control,Other,9305806.0,
632,1159524,1,1,,11113412,33032,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
633,1159524,1,1,,144206604,33032,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
634,1159580,2,1,,268738146,33032,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
635,1159607,2,1,,313041729,33032,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
636,1160721,1,1,,103699331,33032,Active,,,0.34,IC50,Displacement of [3H]-AMPA from AMPA receptor in rat brain cortical membranes,Confirmatory,,
637,1160722,1,1,,103699331,33032,Active,,,0.38,IC50,Displacement of [3H]-KA from kainate receptor in rat brain cortical membranes,Confirmatory,,
638,1160723,1,1,,103699331,33032,Active,,,0.2,Ki,Displacement of [3H]CGP-39653 from NMDA receptor in rat brain cortical membranes,Confirmatory,,
639,1160724,1,2,,103699331,33032,Active,311033443.0,2911.0,1.6,EC50,Agonist activity at human mGluR1 receptor expressed in HEK cells,Confirmatory,,
640,1160725,1,2,,103699331,33032,Active,76803802.0,2912.0,1.8,EC50,Agonist activity at human mGluR2 receptor expressed in HEK cells,Confirmatory,,
641,1160726,1,2,,103699331,33032,Active,76803803.0,2913.0,0.06,EC50,Agonist activity at human mGluR3 receptor expressed in HEK cells,Confirmatory,,
642,1160727,1,2,,103699331,33032,Active,2495077.0,2914.0,3.2,EC50,Agonist activity at human mGluR4 receptor expressed in HEK cells,Confirmatory,,
643,1160728,1,2,,103699331,33032,Active,1709020.0,2915.0,4.7,EC50,Agonist activity at human mGluR5 receptor expressed in HEK cells,Confirmatory,,
644,1160729,1,2,,103699331,33032,Unspecified,2495078.0,2917.0,1180.0,EC50,Agonist activity at human mGluR7 receptor expressed in HEK cells,Confirmatory,,
645,1160730,1,2,,103699331,33032,Active,311033443.0,2911.0,1.58489,Ki,Displacement of [3H]-Quisqualate from human mGluR1 receptor expressed in HEK cells,Confirmatory,,
646,1160731,1,2,,103699331,33032,Active,76803802.0,2912.0,1.8197,Ki,Displacement of [3H]-LY341495 from human mGluR2 receptor expressed in HEK cells,Confirmatory,,
647,1160732,1,2,,103699331,33032,Active,76803803.0,2913.0,0.05754,Ki,Binding affinity to human mGluR3 receptor expressed in HEK cells,Confirmatory,,
648,1160733,1,2,,103699331,33032,Active,2495077.0,2914.0,3.2359400000000003,Ki,Displacement of [3H]-L-AP4 from human mGluR4 receptor expressed in HEK cells,Confirmatory,,
649,1160734,1,2,,103699331,33032,Active,1709020.0,2915.0,4.67735,Ki,Displacement of [3H]-Quisqualate from human mGluR5 receptor expressed in HEK cells,Confirmatory,,
650,1160735,1,2,,103699331,33032,Unspecified,2495078.0,2917.0,1174.9,Ki,Binding affinity to human mGluR7 receptor expressed in HEK cells,Confirmatory,,
651,1207050,1,2,,103699331,33032,Active,400253.0,24415.0,18.25,EC50,Agonist activity at rat mGluR2 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay,Confirmatory,25958247.0,
652,1207051,1,2,,103699331,33032,Active,400255.0,24417.0,12.57,EC50,Agonist activity at rat mGluR4 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay,Confirmatory,25958247.0,
653,1207053,1,2,,103699331,33032,Unspecified,547903.0,24419.0,82.21,EC50,Agonist activity at rat mGluR6 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay,Confirmatory,25958247.0,
654,1207054,1,2,,103699331,33032,Unspecified,547904.0,81672.0,100.0,EC50,Agonist activity at rat mGluR7 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay,Confirmatory,25958247.0,
655,1207055,1,2,,103699331,33032,Active,2495080.0,60590.0,21.47,EC50,Agonist activity at rat mGluR8 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay,Confirmatory,25958247.0,
656,1207056,1,2,,103699331,33032,Active,121300.0,24414.0,23.16,EC50,Agonist activity at rat mGluR1 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay,Confirmatory,25958247.0,
657,1207057,1,2,,103699331,33032,Active,1170947.0,24418.0,13.65,EC50,Agonist activity at rat mGluR5 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay,Confirmatory,25958247.0,
658,1212361,1,2,,103699331,33032,Unspecified,,,,,"Drug uptake in albino F344/DuCrlCrlj rat assessed as radioactivity in glutamic acid in plasma protein at 10 mg/kg, po administered for 5 days by accelerator mass spectrometry analysis",Other,23454829.0,
659,1224859,2,1,,90340902,33032,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
660,1247429,1,1,,103699331,33032,Active,76803802.0,2912.0,1.827,EC50,Agonist activity at wild type human recombinant mGlu2 receptor expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay,Confirmatory,26313429.0,
661,1247430,1,1,,103699331,33032,Unspecified,76803802.0,2912.0,,,Agonist activity at wild type human recombinant mGlu2 receptor expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay relative to glutamate,Other,26313429.0,
662,1247431,1,1,,103699331,33032,Active,76803802.0,2912.0,2.351,EC50,Agonist activity at human recombinant mGlu2 receptor E273D mutant expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay,Confirmatory,26313429.0,
663,1247432,1,1,,103699331,33032,Unspecified,76803802.0,2912.0,,,Agonist activity at human recombinant mGlu2 receptor E273D mutant expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay relative to glutamate,Other,26313429.0,
664,1247433,1,1,,103699331,33032,Active,76803802.0,2912.0,1.767,EC50,Agonist activity at human recombinant mGlu2 receptor L300Q mutant expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay,Confirmatory,26313429.0,
665,1247434,1,1,,103699331,33032,Unspecified,76803802.0,2912.0,,,Agonist activity at human recombinant mGlu2 receptor L300Q mutant expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay relative to glutamate,Other,26313429.0,
666,1247435,1,1,,103699331,33032,Active,76803802.0,2912.0,2.575,EC50,Agonist activity at human recombinant mGlu2 receptor E273D and L300Q mutant expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay,Confirmatory,26313429.0,
667,1247436,1,1,,103699331,33032,Unspecified,76803802.0,2912.0,,,Agonist activity at human recombinant mGlu2 receptor E273D and L300Q mutant expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay relative to glutamate,Other,26313429.0,
668,1247437,1,1,,103699331,33032,Active,76803803.0,2913.0,1.002,EC50,Agonist activity at wild type human recombinant mGlu3 receptor expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay,Confirmatory,26313429.0,
669,1247438,1,1,,103699331,33032,Unspecified,76803803.0,2913.0,,,Agonist activity at wild type human recombinant mGlu3 receptor expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay relative to glutamate,Other,26313429.0,
670,1247439,1,1,,103699331,33032,Active,76803803.0,2913.0,4.1819999999999995,EC50,Agonist activity at human recombinant mGlu3 receptor D279E mutant expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay,Confirmatory,26313429.0,
671,1247440,1,1,,103699331,33032,Unspecified,76803803.0,2913.0,,,Agonist activity at human recombinant mGlu3 receptor D279E mutant expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay relative to glutamate,Other,26313429.0,
672,1247441,1,1,,103699331,33032,Active,76803803.0,2913.0,1.484,EC50,Agonist activity at human recombinant mGlu3 receptor Q306L mutant expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay,Confirmatory,26313429.0,
673,1247442,1,1,,103699331,33032,Unspecified,76803803.0,2913.0,,,Agonist activity at human recombinant mGlu3 receptor Q306L mutant expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay relative to glutamate,Other,26313429.0,
674,1247443,1,1,,103699331,33032,Active,76803803.0,2913.0,5.118,EC50,Agonist activity at human recombinant mGlu3 receptor D279E and Q306L mutant expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay,Confirmatory,26313429.0,
675,1247444,1,1,,103699331,33032,Unspecified,76803803.0,2913.0,,,Agonist activity at human recombinant mGlu3 receptor Q306L and Q306L mutant expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay relative to glutamate,Other,26313429.0,
676,1259310,1,1,,333472290,33032,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
677,1259344,1,1,,144206604,33032,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
678,1259407,1,1,,363905264,33032,Inactive,,,,,CCRIS mutagenicity studies,Other,,
679,1259423,1,2,,354793323,33032,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
